Cargando…
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
Auger radiopharmaceutical therapy is a promising strategy for micrometastatic disease given high linear energy transfer and short range in tissues, potentially limiting normal tissue toxicities. We previously demonstrated anti-tumor efficacy of a small-molecule Auger electron emitter targeting the p...
Autores principales: | Shen, Colette J., Minn, Il, Hobbs, Robert F., Chen, Ying, Josefsson, Anders, Brummet, Mary, Banerjee, Sangeeta R., Brayton, Cory F., Mease, Ronnie C., Pomper, Martin G., Kiess, Ana P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053212/ https://www.ncbi.nlm.nih.gov/pubmed/32194842 http://dx.doi.org/10.7150/thno.38882 |
Ejemplares similares
-
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
por: Boinapally, Srikanth, et al.
Publicado: (2021) -
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
por: Chen, Ying, et al.
Publicado: (2022) -
A Modular Strategy to Prepare Multivalent Inhibitors of Prostate-Specific Membrane Antigen (PSMA)
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2011) -
(64)Cu-Labeled Inhibitors
of Prostate-Specific
Membrane Antigen for PET Imaging of Prostate Cancer
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2014) -
Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer.
por: Deguchi, T., et al.
Publicado: (1997)